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INTRODUCTION
Arteriovenous malformations (AVMs) are congenital lesions
consisted of abnormal connections of the hypertrophied inflow
arteries and shunting through a primitive vascular nidus into
tortuous dilated outflow veins. AVM has the strong potential
of residual mesenchymal cells evolving into malformed embry-
onal tissue so that extreme care should be required not to over-
look its eruption like a volcano. AVM surgery proved extreme-
ly difficult and hazardous, so sclerotherapy with alcohol has
emerged as a main therapeutic choice (1). 
In most cases, sclerotherapy have been done under general
anesthesia because of severe pain, headache, nausea, vomiting,
tachycardia, and fever in an awake patient (2). Various com-
plications can occur such as skin and nerve injury, tissue necro-
sis, elevation of pulmonary artery pressure, pulmonary embo-
lism, hemoglobinuria, and cardiovascular collapse. Total dose
1.0 mL/kg of the maximum volume of ethanol used in treat-
ing patients with AVM in most clinic is based on the clinical
experience, but the safety of this dose has not been confirmed
(3, 4). Exceeding doses can cause ethanol toxicity which elic-
it the possibility of various central nervous system effects (5),
arrhythmias (6), spasms of coronary (7) and cerebral (8) vessels,
and elevation of pulmonary artery pressure (1). It is important
to predict the serum ethanol levels for the prevention of exces-
sive alcohol intoxication after injection of alcohol into the
vascular nidus during sclerotherapy. In the AVMs, systemic
serum ethanol level may rise more easily than in other vascu-
lar malformations because of high blood flow and large drain-
ing veins. But few reports have been published about the serum
ethanol levels after alcohol sclerotherapy in the AVMs.
We evaluated the relationship between the serum ethanol lev-
els and other factors such as the dose of ethanol injected, and
location of lesions, forms of flow occlusion, and resistive index




Because of concerns regarding possible cardiac and central
nervous system effects, serum ethanol levels have been routine-
ly obtained after all sclerotherapy. Between January 1998 and
December 2001, ninety patients with AVM over the age of
18 yr, ASA class I-II physical status were enrolled (M:F=51:
39). Exclusion criteria were abnormal liver or renal function
test and history of drug or alcohol abuse. Average age was 29.7
±10.4 yr, and body weight was 57.8±12.8 kg. The follow-
ing locations were treated: upper extremities (n=30), lower
extremities (n=34), head and neck (n=20), and others (n=6).
Procedure
All procedures were performed by two radiologists under
general anesthesia. Sclerotherapy of AVMs involved cannula-
tion of femoral or radial artery and selective catheterization
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Serum Ethanol Levels after Alcohol Sclerotherapy of Arteriovenous
Malformations
We analyzed the effects of several factors on the serum ethanol levels after alcohol
sclerotherapy in the arteriovenous malformations (AVMs) retrospectively. Blood
ethanol level, amounts of given alcohol, location of lesions, methods of flow control,
and Doppler resistive index (RI) were analyzed. The results of linear regression anal-
ysis showed that the amount of alcohol administered was the predictor of serum et-
hanol level (r
2=0.75, p<0.001). The average amount of injected alcohol was 0.89 mL/
kg in the patients with the serum levels above the legal intoxication level (>80 mg/dL).
Location of the lesions was not related with the serum ethanol level (p=0.643), and
other variables such as forms of flow control and RI were not related to the serum
ethanol level after controlling for injected amounts of alcohol (analysis of covariance).
It is recommended to keep an eye on the possibility of intoxication when using the
amounts of alcohol exceeding 0.89 mL/kg in the sclerotherapy of AVMs. 
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of supplying arteries with a guiding catheter. After angio-
graphy, a microcatheter was inserted into the feeding arteries
and advanced as close to the nidus as possible. Ethanol was
injected into superselected appropriate vessels during inflow
occlusion and various vascular occlusion techniques such as
torniquet, occlusion balloon catheter, and external manual
compression were employed for the stasis of the flow. Radio-
logist determined the amount and the rate of injection of
ethanol by the flow-volume characteristics of the malforma-
tions. The maximum volume of pure ethanol used did not
exceed 1.0 mL/kg in 80% patients. The same procedure was
done repeatedly when necessary. At the end of the procedure,
patients were transferred to the recovery room and blood was
sampled for immediate measurement of plasma ethanol level.
The duration from the first ethanol injection to blood sampling
was 72.5±21.0 min. Ethanol concentrations were determined
by using gas chromatography (Hewlett-Packard 5890, Wal-
tham, MA, U.S.A.).
Anesthesia
Preanesthetic medication was not done, and anesthesia was
induced with thiopental sodium 4-5 mg/kg, vecuronium 0.1-
0.15 mg/kg, and maintained with O2 1 L/min, medical air
1 L/min, and enflurane 1-3.5 vol%. We monitored radial
artery pressure, pulmonary artery pressure via Swan-Ganz
catheter inserted into the internal jugular vein, EKG, periph-
eral oxygen saturation, end-tidal carbon dioxide level, body
temperature and urine output. After procedures, patients were
transferred to the recovery room in the intubated state. 
Variables
Total amounts of alcohol injected, the methods of the flow
occlusion, and locations of the malformations were examined.
Resistive indices of the feeding artery (RI=Vmaxsys-Venddias/
Vmaxsys, described by Pourcelot (9), where Vmaxsys is the maximum
systolic velocity and Venddias is end diastolic velocity) were ob-
tained by using Duplex Doppler image in patients with AVMs
in the extremities (n=30).
Statistical Anaylsis
The relationship between the volume of ethanol adminis-
tered and the serum ethanol level was determined by linear
regression. And location of lesions, forms of the flow control,
and RI ratio were tested as predicting variables with being
evaluated the influences on the serum ethanol levels after con-
trolling for amounts of ethanol (analysis of covariance). The
probability value for significance was set at p<0.05. All tests
were performed using SPSS 4.0 version for Windows.
RESULTS
The relationship between plasma ethanol level and amount
of injected ethanol was significant. The model of simple regres-
sion yielded a linear regression with a significant Spearman’s
correlation coefficient (r2=0.75, p<0.001, Fig. 1).
In all locations, there was a positive correlation between
serum ethanol levels and injected alcohol amounts (p<0.001),
and the strength of the relationship was not different accord-
ing to the locations (p=0.939, Table 1). After controlling for
the amounts of injected alcohol, there was no significant dif-
ference in serum ethanol levels according to the locations of
lesions (p=0.643, Table 1). 
And the methods of flow occlusion did not relate to serum
ethanol levels (p=0.720). 
The Doppler RI was lower in the involved extremities with
AVMs compared to that in the contralateral side. The RI of
the feeding artery was 0.67±0.14 in the involved side and
1.08±0.23 in the contralateral side. The ratio of RI of the
feeding artery to the contralateral side was 0.61±0.18. The
RI value was not the predictor of serum ethanol level (p=0.760,
r2=0.01).
DISCUSSION
The results of this study demonstrated a strong correlation
between the serum ethanol level and the amount of ethanol
Values are mean±S.D. Corrected serum levels: serum ethanol levels
after controlling for injected amounts of alcohol. There were no differences








Total (n=90) 0.56±0.31 56.6±36.5
Locations
Head and neck (n=20) 0.38±0.28 37.0±29.9 48.8±27.5
Upper extremity (n=30) 0.49±0.28 50.6±33.0 51.8±28.9
Lower extremity (n=34) 0.76±0.26 74.4±36.7 47.2±27.7
Others (n=6) 0.43±0.30 46.0±30.9 56.5±30.1
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Fig. 1. Relationship between amounts of injected ethanol and serum
ethanol levels in all 90 patients (y=101.4x-0.76, r
2=0.75).Alcohol Sclerotherapy and Serum Ethanol Level 53
injected during sclerotherapy of AVMs. Correlation of the
amount of ethanol administered with the serum ethanol level
indicates to carefully monitor the ethanol dose during the scle-
rotherapy of AVMs. Ninety to 98% of injected alcohol is re-
moved in the liver by alcohol dehydrogenase. There are no
pharmacokinetic studies during alcohol sclerotherapy, but we
can assume that elimination process is similar to that after oral
intake. Elimination proceeds at a constant rate (zero-order
kinetics) of 20 mg/dL/hr in adults and 18.6 mg/dL/hr in ado-
lescents and children after oral intake (10). In most cases, alco-
hol injection was done repeatedly during the procedure and
the serum ethanol levels were measured in the recovery room
between 52 min and 93 min (72.5±21.0 min) after the first
ethanol injection. The difference of sampling timing, maxi-
mum 40 min, can theoretically induce the difference of serum
ethanol levels by about 14 mg/dL, which value is within the
range of standard deviation of serum levels (56.6±36.5 mg/
dL). So, the serum ethanol level measured in the recovery room
may not reflect the peak serum ethanol level but may reflect
the cumulative serum ethanol level. Further studies are war-
ranted to estimate the peak serum ethanol level after every
alcohol injection during the procedure.
When alcohol is injected into the vessel, ethanol induces
thrombosis by denaturing proteins, dehydrating vascular
endothelial cells, precipitating their protoplasm, and denud-
ing the vascular wall. And thrombus formation is promoted
by the vascular spasm, perivascular necrosis, and stagnations
of red blood cells in the arteriole (11). Since ethanol completely
destroys the endothelial cells, the phenomenon of recanaliza-
tion and neovascular recruitment are noticeably absent (12).
In our study, the average amount of alcohol injected was higher
than 0.89 mL/kg in the patients with serum levels above the
legal intoxication level (>80 mg/dL). Yakes et al. reported
complication rates of 10-30% related to alcohol sclerotherapy
(1). In our study, there were no specific complications in pa-
tients with the serum ethanol levels below 20 mg/dL (n=15).
However, elevation of pulmonary artery pressure (n=3) dur-
ing procedure, pulmonary edema (n=1) after procedure, and
hemoglobinuria (n=2) occurred among the 12 cases with the
serum ethanol levels above the 100 mg/dL. Pulmonary artery
catheterization and arterial blood pressure monitoring are essen-
tial to minimize the possibility of cardiopulmonary compli-
cation during the procedure (1). Once pulmonary artery pres-
sure begin to rise, it is best not to inject any more ethanol and
wait until the pulmonary artery pressures return to normal. If
pulmonary artery pressures become pathologically high, the
infusion of nitroglycerin or prostaglandin E1through the Swan-
Ganz line lowers the pulmonary artery pressure. We did not
observe the complication of neurology such as the change of
speech, mood, and ataxia after the procedure because of anes-
thesia and narcotics used for analgesia.
We expected that serum ethanol level should be influenced
by the locations of malformations because of different venous
return according to the locations of lesions. In our study, the
amounts of alcohol injected in the lower extremities were
larger than other sites (0.76 mL/kg : 0.39 mL/kg), it might
reflect the common idea of the radiologists that extremity is
safer than other sites. Contrary to our expectation, the loca-
tion of malformations was not the predictor of serum ethanol
levels. First, this result may reflect the appropriate effects of
the occlusion techniques before injecting alcohol. Second, when
alcohol is injected into the nidus during sclerotherapy, absorp-
tion of the alcohol may occur both at the damaged vessel wall
itself and by the draining veins. Our result implies the absorp-
tion of alcohol through the damaged endothelial vessel wall
plays an important role on the serum ethanol levels.
Kusano and Ohta reported the average serum ethanol lev-
els of 58.2 mg/dL (average amounts of alcohol, 0.17 mL/kg) in
the transcatheter obliteration of renal artery without balloon
occlusion in 11 dogs, which value is higher compared with our
results (13). But, three ways for the stasis of blood did not have
any influence on the serum ethanol levels. We used torniquet
in extremities, manual compression in the head and neck, and
occlusive balloon in other sites. This result shows that man-
ual compression is as effective as other techniques.
Duplex Doppler image is an essential tool in the diagnosis
and the follow-up of AVMs. AVMs demonstrate high velocity
and low resistance waveforms. In our study, the average RI
ratio to the contralateral side in the cases of extremities was
0.61, but showed no relationship with serum ethanol levels.
This study showed that the RI ratio was not an important
factor on the systemic washout of injected alcohol. As the mal-
formations serially become ablated, the RI and the flow vol-
umes become normalized (14).
In conclusion, the serum ethanol levels related to the am-
ounts of injected alcohol, not to the locations of malformations,
forms of flow occlusion and characteristics of the flow in the
AVMs during sclerotherapy. It is prudent to keep an eye on
the possibility of intoxication when using the amounts of alco-
hol exceeding 0.89 mL/kg in the sclerotherapy of AVMs.
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